Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Business Gazette.
Press releases published on March 27, 2025
Nanobiotix annonce les premières données issues de la partie escalade de dose completée d’une étude de Phase 1 évaluant JNJ-1900 (NBTXR3) en traitement de 2L+ pour les patients atteints d’un CPNPC localement avancé
GlobeNewswire
·
March 27, 2025
Les données montrent un profil de sécurité favorable et confirment la faisabilité de l’injection chez 12 patients atteints d’un cancer du poumon (CPNPC) localement avancé éligibles à une ré-irradiation et pour lesquels les lignes de traitement antérieures …
Tempest Reports Year End 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 27, 2025
• Granted Both Orphan Drug …
Acuity Inc. Declares Quarterly Dividend
GlobeNewswire
·
March 27, 2025
Atlanta, March 27, 2025 (GLOBE NEWSWIRE) -- Acuity Inc. (NYSE: AYI) will pay a quarterly dividend of 17 cents per share. The dividend is payable on May 1, 2025, to shareholders of record on April 18, 2025. About Acuity Acuity Inc. (NYSE: AYI) is a …
Joseph Nigro Appointed to Eos Energy Enterprises Board of Directors
GlobeNewswire
·
March 27, 2025
EDISON, N.J., March 27, 2025 (GLOBE NEWSWIRE) -- Eos Energy Enterprises, Inc. (NASDAQ: EOSE) ("Eos" or the “Company”), America’s leading innovator in designing, manufacturing, and providing zinc-based long duration energy storage systems sourced and …
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update
GlobeNewswire
·
March 27, 2025
BOCA RATON, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- INmune Bio Inc. (NASDAQ: INMB) (the “Company”), a clinical-stage inflammation and immunology company focused on developing treatments that harness the patient’s innate immune system to fight disease, …
Lifecore Biomedical to Report Financial Results for Third Quarter of Fiscal 2025 on April 3, 2025
GlobeNewswire
·
March 27, 2025
CHASKA, Minn., March 27, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that it will report financial results for the third …
Wintrust Names New Leader for Brand, Engagement, and Impact
GlobeNewswire
·
March 27, 2025
ROSEMONT, Ill., March 27, 2025 (GLOBE NEWSWIRE) -- Wintrust Financial Corporation (Nasdaq: WTFC) today announced Amy Yuhn has been named Executive Vice President for Brand, Engagement, and Impact, a new position that will oversee marketing, corporate …
Elutia Announces GPO Agreement with Advantus Health Partners to Expand Access to EluPro™
GlobeNewswire
·
March 27, 2025
Seventh GPO Agreement Signed Since EluPro’s Launch SILVER SPRING, Md., March 27, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia” or the “Company”), a pioneer in drug-eluting biomatrix products, announced that it has entered into an agreement …
CAMP4 Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
– Phase 1 clinical trial of CMP-CPS-001 in Urea Cycle Disorders (UCDs) ongoing, with dosing completed in two of four multiple ascending dose (MAD) cohorts; safety, pharmacokinetic, and pharmacodynamic data anticipated in Q4 2025 – Initiation of expansion …
Global Water Completes $32.2 Million Public Offering of Common Stock; Underwriters Exercise Full Over-Allotment Option
GlobeNewswire
·
March 27, 2025
PHOENIX, March 27, 2025 (GLOBE NEWSWIRE) -- Global Water Resources, Inc. (NASDAQ: GWRS), a pure- play water resource management company, today announced that it completed a public offering of 3,220,000 shares of its common stock at a previously disclosed …
Crinetics Pharmaceuticals Announces European Medicines Agency (EMA) Validation of Marketing Authorization Application (MAA) and Orphan Drug Designation (ODD) for Paltusotine in Acromegaly
GlobeNewswire
·
March 27, 2025
SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that the European Medicines Agency (EMA) has validated the Marketing Authorization Application (MAA) for paltusotine, the first once-daily, oral, …
CTO Realty Growth Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- CTO Realty Growth (NYSE: CTO) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, May 1, 2025. A …
Alpine Income Property Trust Announces First Quarter 2025 Earnings Release and Conference Call Information
GlobeNewswire
·
March 27, 2025
WINTER PARK, Fla., March 27, 2025 (GLOBE NEWSWIRE) -- Alpine Income Property Trust, Inc. (NYSE: PINE) (the “Company”) announced today that it will report its financial and operating results for the first quarter of 2025 after the market closes on Thursday, …
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides a Corporate Update
GlobeNewswire
·
March 27, 2025
HORSHAM, Pa., March 27, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of …
Jones Soda Sets Fourth Quarter and Full Year 2024 Conference Call for Tuesday, April 1, 2025, at 9:00 a.m. ET
GlobeNewswire
·
March 27, 2025
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Jones Soda Co. (CSE: JSDA, OTCQB: JSDA) (“Jones Soda” or the “Company”), today announced it will hold a conference call on Tuesday, April 1, 2025, at 9:00 a.m. Eastern time to discuss its financial and …
SeaStar Medical Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates
GlobeNewswire
·
March 27, 2025
DENVER, March 27, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company focused on transforming treatments for critically ill patients facing organ failure and potential loss of life announced …
Accolade Stockholders Approve Merger Between Accolade and Transcarent
GlobeNewswire
·
March 27, 2025
SEATTLE, March 27, 2025 (GLOBE NEWSWIRE) -- Accolade (NASDAQ:ACCD) announced that Accolade stockholders voted to approve the merger with Transcarent at the Accolade special meeting of stockholders (the “Special Meeting”) held earlier today. The final, …
BioAtla Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Progress
GlobeNewswire
·
March 27, 2025
CAB-EpCAM x CAB-CD3 (BA3182) Phase 1 dose-escalation study continues with data readout expected mid-2025; Dose expansion data readout anticipated 1H 2026 Mecbotamab vedotin (CAB-AXL-ADC) Q2W dosing regimen associated with exceptional overall survival (OS) …
Hour Loop Reports Full Year 2024 Results
GlobeNewswire
·
March 27, 2025
Profitability Continues Despite Challenges for the Overall Economy Provides Full Year 2025 Revenue and Net Income Guidance Redmond, WA, March 27, 2025 (GLOBE NEWSWIRE) -- Hour Loop, Inc. (NASDAQ: HOUR) (“Hour Loop”), a leading online retailer, announces …
Clearside Biomedical Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
·
March 27, 2025
- Successful End-of-Phase 2 Meeting with FDA Results in Alignment on Phase 3 Plans for CLS-AX in Wet AMD - - Asia-Pacific Partner’s New Drug Application for ARCATUS® (XIPERE®) for Uveitic Macular Edema Accepted for Regulatory Review in China - - Multiple …